Test Directory
| Test Code | |||||||||||||
| FSIMB | |||||||||||||
| Test Name | |||||||||||||
| IGH::MAFB, t(14;20)(q32;q12) by FISH | |||||||||||||
| CPT Codes | |||||||||||||
| 88237, 8837726, 88377TC | |||||||||||||
| Included Tests | |||||||||||||
|
|||||||||||||
| Expected Turnaround Time | |||||||||||||
| 3-5 business days | |||||||||||||
| Clinical Utility | |||||||||||||
|
Plasma cell myeloma (PCM) is a complex and genetically heterogenous hematological malignancy involving clonal proliferation of plasma cells in bone marrow. Standard karyotype and fluorescence in situ hybridization (FISH) evaluation of bone marrow is required in the initial diagnostic workup to risk stratify patients based on their cytogenetic status. Primary cytogenetic events are classified as either hyperdiploid or non-hyperdiploid. Common in non-hyperdiploid cases is rearrangement of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32.33, most commonly with the cell-cycle regulator cyclin D1 (CCND1) gene at 11q13.3, and to a lesser extent fibroblast growth factor receptor 3 (FGFR3)/multiple myeloma SET domain (MMSET) genes at 4p16.3 or the MAF gene at 16q23.2. The rarest of these IGH translocations involves the MAFB gene at 20q12. Approximately 40-50% of myeloma cases demonstrate an IGH gene rearrangement. The t(14;20)(q32;q12) is the rarest of the five most common IGH-rearrangements, found in approximately 1% of cases [Manier et al, 2016]. |
|||||||||||||
| Specimen and Container Info | |||||||||||||
|
|||||||||||||
| Collection Instructions | |||||||||||||
|
|||||||||||||
| Processing and Submission Instructions | |||||||||||||
|
Each specimen must be accompanied by a requisition form, script, electronic order or physician note. Each order must indicate the reason for testing (diagnosis). |
|||||||||||||
| Transport Instructions | |||||||||||||
|
|||||||||||||
| Stability Requirements | |||||||||||||
|
|||||||||||||
| Causes for Rejection | |||||||||||||
|
|||||||||||||
| Methodology | |||||||||||||
| FISH, Fluorescence In-Situ Hybridization | |||||||||||||
| Reference Intervals | |||||||||||||
|
In a normal cell, the expected signal pattern is two orange signals and two green signals. In an abnormal cell containing a typical translocation, the expected signal pattern is one orange signal, one green signal, and two fused signals. |
|||||||||||||
| Performing Location | |||||||||||||
| Roble Road Core Laboratory | |||||||||||||
| Alternate Names | |||||||||||||
|
|||||||||||||
| Testing Schedule | |||||||||||||
| Routine, Monday - Friday no holidays | |||||||||||||
| Disease Group | |||||||||||||
| Cytogenetic Tests | |||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.